Cerus News and Activities

Presence

Cerus develops blood safety technologies for blood centers, hospitals, and health systems. Its products help reduce pathogen risks in platelets, plasma, and red blood cells used in transfusion care.

Cerus products and services overview:

Blood safety systems
Pathogen reduction
Platelet treatment
Plasma treatment
Red cell treatment
Transfusion support

Revenue: ~$180 million

Employees: 650

Headquarters: Concord, United States (USA)

Cerus is one of the...

Cerus is a company listed under the stock ticker CERS (US).

Executives

View the org chart displaying its 22 main executives

Most searched biographies at Cerus

Popular executive movements at Cerus

Vivek Jayaraman who is Chief Operating Officer, will be promoted to President and Chief Executive Officer on Jul. 1, 2026 (posted on March 17 2026).
William Greenman who is Director, President and Chief Executive Officer, will become Executive Chairman of the Board on Jun. 1, 2026 (posted on March 17 2026).

Create your alert
to follow the executive moves at Cerus.